Next Article in Journal
Psychosocial Impact of Predictive Genetic Testing in Hereditary Heart Diseases: The PREDICT Study
Previous Article in Journal
ECG Indices Poorly Predict Left Ventricular Hypertrophy and Are Applicable Only in Individuals with Low Cardiovascular Risk
 
 
Review
Peer-Review Record

Adenosine and the Cardiovascular System: The Good and the Bad

J. Clin. Med. 2020, 9(5), 1366; https://doi.org/10.3390/jcm9051366
by Régis Guieu 1,2,*, Jean-Claude Deharo 1,3, Baptiste Maille 1,3, Lia Crotti 4,5,6,7, Ermino Torresani 8, Michele Brignole 8,9 and Gianfranco Parati 4,8
Reviewer 1: Anonymous
Reviewer 2: Anonymous
J. Clin. Med. 2020, 9(5), 1366; https://doi.org/10.3390/jcm9051366
Submission received: 5 April 2020 / Revised: 27 April 2020 / Accepted: 29 April 2020 / Published: 6 May 2020
(This article belongs to the Section Cardiology)

Round 1

Reviewer 1 Report

This review article introduces the influence of adenosine on the cardiovascular system, particularly on some common cardiovascular diseases and conditions, such as hypertension, heart failure, and arrhythmias. Given a short half-life of the adenosine and its opposite action through affecting different receptors, including A1R, A2AR, A2BR, and A3R, it would be more interesting if this article could make a perspective about the application of the selective agonist or antagonist of adenosine receptor to treat cardiovascular diseases. With this respect, for instance, a specific A2AR agonist or A1R antagonist to lower blood pressure in hypertension.

Author Response

Dear Sir

As suggested, the sentence" In this perspective the use of specific A2A R agents or A1R antagonists to lower blood pressure should be promising"

has been added at the end of 7.7 paragraph

Reviewer 2 Report

The authors have done a good job reviewing adenosine in the cardiovascular system.

One aspect which is missing and should be highlighted in at least a few paragraphs would be the impact of adenosine on regulation of vascular healing and the post arterial repair.

There is a broad literature on targeting A2A and A2B for vascular healing after injury.

Author Response

Dear Sir

A new paragraph has been added. In this context, 8 new references (137-144) have been added.

7.6       Adenosine  and vascular injury and repair

Adenosine also plays a major role in promoting wound healing and vascular tissues repair [137]. Thus A2adenosine receptor subtypes are required to new matrix production and angiogenesis while A1 R up regulates vascular endothelial growth factor from monocytes and contributes to new vessels formation [138]. The activation of adenosine receptors promotes endothelial cell proliferation and stimulates angiogenesis factors production. In this context, activation of A2A R promotes wound healing during experimental tissue injury [139].

Vascular muscle cell proliferation is an important component of vascular remodeling which is regulated partly through A2B receptors [140] and it was shown that activation of A2BR protects against vascular injury [141]. 

Finally drugs that increase adenosine plasma levels, improved endothelial function [142]. Thus targeting A2A and A2B receptors are promising for vascular healing after injury [143-144].

 

Back to TopTop